Posts

The Myth of the Visionary Biotech Founder

Image
The visionary biotech founder is usually a story device, not an operating model. If you want to understand who really builds durable biotech companies, you need to look past charisma and study the mix of science, execution, governance, hiring, and capital discipline that keeps a company alive long enough to matter. You are not reading this to hear another founder legend repeated back to you. You are reading it to separate signal from branding, so you can evaluate companies more sharply, judge leadership more accurately, and make better calls as an operator, investor, founder, or board member. In biotech, mythology wastes time. Operating truth preserves capital, talent, and momentum. Are Biotech Startups Really Built By Visionary Founders, Or By Teams? If you spend enough time around venture-backed biotech, you will notice that the public story is often built around one face and one name. The company appears to come from a single brilliant scientist, a bold chief executive officer, or ...

7 Best Tools for CRISPR Off Target Analysis

Image
For credible CRISPR off-target analysis, build a stack: use in-silico nomination to rank and shortlist risk, then use a genome-wide discovery assay when the decision is expensive, time-sensitive, or high-stakes. This guide breaks down seven tools and methods that working labs lean on: three fast computational options for screening, plus four experimental genome-wide assays that show you what actually happened. You’ll get practical selection criteria, what each tool is best at, what it tends to miss, and a workflow that keeps cost and turnaround under control. 1. CRISPOR: Best For Fast Guide Ranking And Practical Off-Target Scoring CRISPOR earns its place because it matches how guide design happens in real projects: you need a quick way to rank multiple candidate guides, flag obvious off-target risk, and walk into experiments with a short list that won’t embarrass you later. The CRISPOR publication emphasizes evaluation of on-target and off-target scoring approaches and integrates the...

If Your Lab Is Still Manual, You Are Already Behind

Image
If your lab is still running on manual handoffs, paper logs, and spreadsheet-driven control, it is already behind on turnaround time, data integrity, and audit readiness. The gap widens every quarter because modern labs are built to move samples and data through connected systems, not through people acting as the integration layer.  This article lays out what “behind” looks like in measurable terms, where manual workflows fail under volume and staffing pressure, and what automation actually fixes when it’s deployed well. You will also get a realistic path to modernization that starts small, protects compliance, and produces results you can defend to leadership with metrics. Why Is A Manual Lab Workflow Considered “Already Behind” In 2026? A manual lab is “behind” when people spend their day moving information instead of producing and releasing reliable results. That shows up as repeated transcription, repeated verification, repeated phone calls, repeated specimen hunting, and repea...

Nirdosh Jagota on Pharma Leadership & Innovation

Image
  I’m excited to share my recent interview, where I talk about my journey in the pharmaceutical industry and the key lessons I’ve learned along the way. Over the course of my 30+ year career, I’ve worked on critical healthcare projects like the Ebola vaccine and explored the transformative power of AI and machine learning in pharma. In this interview, we cover: How leadership plays a pivotal role in shaping pharma’s future The impact of AI in accelerating healthcare innovations Insights into the challenges and rewards of regulatory work My advice for young professionals eager to grow in the pharmaceutical industry Check out the full interview for more insights:  https://www.youtube.com/watch?v=xEd_i6Exoy0 .

The Ethics of Genetic Modification and Cloning: What You Need to Know

Image
  Genetic modification and cloning are two of the most controversial and debated topics in modern science. These technologies hold immense potential for advancing medicine, agriculture, and other fields, but they also raise significant ethical concerns. As these technologies continue to develop, it’s important to understand the ethical implications they carry. This article explores the key ethical issues surrounding genetic modification and cloning, providing a comprehensive overview of what you need to know. Understanding Genetic Modification and Cloning Genetic modification involves altering the DNA of an organism to achieve desired traits, such as disease resistance in crops or enhanced growth in animals. Cloning, on the other hand, is the process of creating a genetically identical copy of an organism. Both technologies have been used in various fields, from agriculture to medicine, and have the potential to revolutionize how we approach problems like food security and genetic...

Antibiotic Stewardship Revolutionized: The Interactive Antibiogram Tool

Image
Antibiotic resistance is a growing global health threat, making effective antibiotic stewardship more critical than ever. The Interactive Antibiogram Tool represents a significant advancement in the fight against antimicrobial resistance, providing healthcare professionals with real-time, actionable data to guide antibiotic prescribing practices. This article explores how this innovative tool enhances antibiotic stewardship, its features, applications, and the impact it can have on public health. By leveraging interactive antibiograms, we can optimize antibiotic use, improve patient outcomes, and curb the spread of resistant infections. The advent of such tools marks a pivotal moment in our approach to managing antibiotics and tackling the formidable challenge of resistance. Understanding Antibiotic Stewardship Antibiotic stewardship refers to coordinated interventions designed to improve and measure the appropriate use of antibiotics by promoting the selection of the optimal antimicr...